Water-Soluble Ruthenium(III)-Dimethyl Sulfoxide Complexes: Chemical Behaviour and Pharmaceutical Properties

por Mestroni, G., Alessio, E., Sava, G., Pacor, S., Coluccia, M., Boccarelli, A.
Publicado 1994

Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion

por Bergamo, A., Masi, A., Jakupec, M. A., Keppler, B. K., Sava, G.
Publicado 2009

Efficacy of 5-FU Combined to Na[trans-RuCl(4)(DMSO)Im], A Novel Selective Antimetastatic Agent, on the Survival Time of Mice With P388 Leukemia, P388/DDP subline and MCa Mammary Ca...

por Coluccia, M., Sava, G., Salerno, G., Bergamo, A., Pacor, S., Mestroni, G., Alessio, E.
Publicado 1995

Reduction of Lung Metastases by Na[trans-RuCl(4)(DMSO)Im] is not Coupled With the Induction of Chemical Xenogenization

por Sava, G., Salerno, G., Bergamo, A., Cocchietto, M., Gagliardi, R., Alessio, E., Mestroni, G.
Publicado 1996

Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers

por Morbidelli, L, Donnini, S, Filippi, S, Messori, L, Piccioli, F, Orioli, P, Sava, G, Ziche, M
Publicado 2003

Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A

por Vacca, A, Bruno, M, Boccarelli, A, Coluccia, M, Ribatti, D, Bergamo, A, Garbisa, S, Sartor, L, Sava, G
Publicado 2002

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk

por Sava, G P, Speedy, H E, Di Bernardo, M C, Dyer, M J S, Holroyd, A, Sunter, N J, Marr, H, Mansouri, L, Deaglio, S, Karabon, L, Frydecka, I, Jamroziak, K, Woszczyk, D, Juliusson, G, Smedby, K E, Jayne, S, Majid, A, Wang, Y, Dearden, C, Hall, A G, Mainou-Fowler, T, Jackson, G H, Summerfield, G, Harris, R J, Pettitt, A R, Allsup, D J, Bailey, J R, Pratt, G, Pepper, C, Fegan, C, Rosenquist, R, Catovsky, D, Allan, J M, Houlston, R S
Publicado 2015